Displaying drugs 14051 - 14075 of 14522 in total
Levomethadone
Experimental
Sequifenadine
Experimental
Picloxydine
Experimental
Sulbentine
Experimental
Xibornol
Experimental
Guanoclor
Experimental
Clofibride
Experimental
Bisoxatin acetate
Experimental
Motexafin lutetium
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)
Experimental
Talviraline
Talviraline has been used in trials studying the treatment of HIV Infections.
Investigational
4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
Experimental
Dexetimide
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
Withdrawn
Mephenoxalone
Experimental
Candoxatril
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
A-98881
Experimental
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol
Experimental
BMS-564929
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Displaying drugs 14051 - 14075 of 14522 in total